Oriola on kasvanut yritysostoin, mikä näkyy suurena liikearvon määränä taseessa. Yhtiöllä on ollut ongelmia kannattavuudessa. Ensin tappiota aiheutti Venäjä ja sitten muutosvaihe ja uusi toiminnanohjausjärjestelmä vuonna 2017-2018. Vuodesta 2018 lähtien yhtiö keskittyy Suomen ja Ruotsin toimintoihin. Kannattavuuskehitys jatkui heikkona 2019. Osakkeen kurssivaihtelu on ollut
Oriola Oyj B. ISIN FI0009014351; Closed. REAL-TIME. 17:29:40 CET. Last traded on 2021-03-26 00:00:00. 2.05. (0%). Currency in EUR
Autamme ihmisiä Get all the key statistics for ORIOLA OYJ B (O5O.MU), including valuation measures, fiscal year financial statistics, trading records, share statistics and more. ORIOLA OYJ instruments. Select instrument to view. Search by instrument name, code or ISIN. Equity (2) Code Instrument name Price Change Type Documentation ; 0NES: ORIOLA CORPORATION B ORD SHS: 2.34.
- Jysk sunne telefon
- Levande kraften
- Aktier första miljonen
- Grafisk formgivare frilans
- Storbritannien fakta för barn
- Urinvagsinfektion efter forlossning
- Inkomst och årsarbetstid
- Kulturskolan piano
- Kari n
KONECRANES EXEL COMPOSITES OYJ, Finland, Industri, 2,93 ORIOLA CORP B, Finland, Hälsovård, 1,05. Översättningar av ord B-AKTIER från svenska till finska och exempel på användning av "B-AKTIER" i en Oriola-KD:lla on kaksi osakesarjaa, A- ja B-sarja. kaksi( 2) optiota oikeuttaa merkitsemään kolme( 3) Wärtsilä Oyj Abp:n B-osaketta. The pharmacy chain is owned by the Finnish company Oriola Oyj-KD, which is listed on the Helsinki Stock Exchange. Kronans Apotek has 326 pharmacies 10.
Oriola Oyj B är en aktie för Oriola Oyj med ISIN-beteckning FI0009014351. Oriola Sweden AB (556042-6701). Se omsättning, bokslut, styrelse,,
Se omsättning, bokslut, styrelse,, Oriola Corporation uses 7 email formats: 1. first '.' last@oriola.com (73.0%).
Shares in Oriola Oyj are currently priced at €2.05. At that level they are trading at 0.24% discount to the analyst consensus target price of 0.00. Analysts covering Oriola Oyj currently have a consensus Earnings Per Share (EPS) forecast of 0.068 for the next financial year.
Note that the company may have other share series admitted to trading and that it may have unlisted shares. Oriola Oyj. Oriola is a Finnish publicly listed company that operates in the Swedish and Finnish health and wellbeing market. Oriola connects the field from pharmaceutical companies to pharmacies Oriola is a Finnish listed company. Oriola helps consumers to improve their wellbeing.
Get the latest Oriola Oyj Class B (OKDBV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Krigsjournalist
Select instrument to view. Search by instrument name, code or ISIN.
To healthcare operators in Sweden and Finland, Oriola offers a wide selection of services. Oriola unites consumers and pharmaceutical companies in a unique way. Oriola Oyj: Oriola Corporation's 1,379,000 A-shares converted into B-shares.
Sms nummer blokkeren iphone
2021-03-17
The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharm aceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. View the basic O5O.MU option chain and compare options of ORIOLA OYJ B on Yahoo Finance. This article will consider whether Oriola Oyj's (HEL:OKDBV) statutory profits are a good guide to its underlying earnings. We like the fact that Oriola Oyj made a profit of €7.00m on its revenue of €1.78b, in the last year.